Persistence measures the time a medication is used continuously from the start of therapy initiation
At the same time, however, the large insurer Cigna announced it will begin capping out-of-pocket costs at $200 per month, starting next month, for patients using the obesity drugs Wegovy (semaglutide) and Zepbound (tirzepatide) through an add-on to its pharmacy benefit management plans
While pathogens secrete broad-spectrum mucinases that compromise mucus layer integrity, A
Healthcare providers can adjust the treatment regimen by slowing dose escalation, temporarily reducing the dose, or prescribing antiemetic medications when appropriate
Drinking small amounts and avoiding alcohol during dose increases can help reduce side effects
Wegovy is a higher-dose version of semaglutide that was approved in 2021 specifically for weight loss